Suppr超能文献

中度蛋白尿性IgA肾病:进展性病例中个体临床病程的预后预测及类固醇治疗

Moderately proteinuric IgA nephropathy: prognostic prediction of individual clinical courses and steroid therapy in progressive cases.

作者信息

Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Tateno S

机构信息

Department of Medicine, Kitasato University School of Medicine, Sagamihara, Japan.

出版信息

Nephron. 1989;53(3):250-6. doi: 10.1159/000185753.

Abstract

Eighteen of 60 patients with persistent moderate proteinuria between 1.0 and 2.0 g/day and a long-term follow-up of more than 4 years received steroid therapy for a mean period of 18 months. Fifteen of these 18 patients maintained their initial creatinine clearance (CCr) of 70 ml/min or more. The remaining 42 received antithrombocyte drugs and/or nonsteroidal anti-inflammatory drugs, with 31 of them keeping their initial Ccr values of 70 ml/min or more. All 14 cases with initial Ccr values of less than 70 ml/min in both the steroid and nonsteroid groups followed progressive courses, with 12 ending up in hemodialysis. Of the nonsteroid, preserved group of 31 cases, 12 followed a stable course, 10 a progressive course, and the other 9 went into end-stage renal failure necessitating hemodialysis. There were no differences in initial clinical features among these three subgroups. But histological changes were milder in the stable subgroup than in the progressive and hemodialysis subgroups. Further, the total score of eight histological parameters was 6 or less in all but 1 of the cases of the stable subgroup, but 8 or higher in the other two subgroups. Therefore, in the progressive cases alone with initial Ccr values of 70 ml/min or more and high total scores of 7 or more, the long-term clinical courses were compared between steroid and nonsteroid groups (10 and 20 cases, respectively). In the steroid group proteinuria decreased significantly and renal function was preserved well as compared with that in the nonsteroid group.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

60例持续性中度蛋白尿(每日1.0至2.0克)且长期随访超过4年的患者中,18例接受了平均为期18个月的类固醇治疗。这18例患者中有15例维持了初始肌酐清除率(CCr)在70毫升/分钟或更高。其余42例接受抗血小板药物和/或非甾体抗炎药治疗,其中31例维持了初始CCr值在70毫升/分钟或更高。类固醇组和非类固醇组中初始CCr值低于70毫升/分钟的所有14例患者病情均呈进展性,其中12例最终接受血液透析。在非类固醇组中,31例病情稳定的患者中,12例病情稳定,10例病情进展,另外9例进入终末期肾衰竭需要进行血液透析。这三个亚组的初始临床特征没有差异。但稳定亚组的组织学变化比进展性亚组和血液透析亚组更轻。此外,稳定亚组除1例患者外,所有病例的八个组织学参数总分均为6或更低,而其他两个亚组则为8或更高。因此,仅在初始CCr值为70毫升/分钟或更高且总分为7分或更高的进展性病例中,比较了类固醇组和非类固醇组的长期临床病程(分别为10例和20例)。与非类固醇组相比,类固醇组蛋白尿显著减少,肾功能得到良好维持。(摘要截短至250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验